Norepinephrine Versus Phenylephrine for the Prevention of Post Spinal Hypotension in Caesarean Section.
Keywords:
Caesarean section, Hypotension, Norepinephrine, Phenylephrine, spinal, vasopressorAbstract
Background: Hypotension following spinal anesthesia in the cesarean section is common despite adequate fluid loading. The recommended medication to treat spinal hypotension during cesarean section is phenylephrine. Norepinephrine bolus has recently been proposed as an alternative to phenylephrine bolus. Our study's objective was to evaluate the efficacy of bolus doses of phenylephrine and norepinephrine in treating spinal-induced hypotension after cesarean delivery.
Methods: One hundred and eighty parturient, ASA II, aged above 18 years, planning an elective cesarean section under anesthesia were randomly assigned by the lottery method into the two groups. Group P received Phenylephrine 50 µg intravenous bolus, and Group N received 5 µg of Norepinephrine intravenous bolus to prevent spinal-induced hypotension.
Results: The incidence of hypotension after the prophylactic bolus dose of study drugs was 25.6% in group N and 32.2% in group P. The number of rescue bolus doses of the studied drug that were required to treat hypotension was lower in Group N than in group P (25.6% vs 32.2 % ). The Mephentermine that was required to treat hypotension was also lower in Group N than in Group P (11.1% vs 12.2 % ). The changes in heart rate and mean arterial pressure after the injection of the study drug were comparable.
Conclusion: Prophylactic Norepinephrine and Phenylephrine bolus dose were equally effective in the prevention of spinal-induced hypotension during cesarean section.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author(s) retain the copyright and the full publishing right without restriction under the Creative Commons Attribution 4.0 International License (CC BY 4.0) which allows readers to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material) for any purpose, even commercially, provided the work is properly attributed. (https://creativecommons.org/licenses/by/4.0/).
Author(s) grant the non-exclusive publishing right to the Journal of Karnali Academy of Health Sciences (JKAHS). The publishing rights include the rights to publish, reproduce, distribute, include in indexes or search databases or other media in print or online. The JKAHS may require revisions to the manuscript before acceptance for publication or may choose not to publish it based on the judgement of the editors. Further, JKAHS might retract, withdraw, or publish a correction or other notice after publication, if such publication would be inconsistent with the good publication practices and associated guidelines set forth by the COPE (Committee on Publication Ethics) (https://publicationethics.org/core-practices).
More information about the Creative Commons Attribution 4.0 International License can be found in the webpage of Creative Commons (CC) by following the link provided below: https://creativecommons.org/licenses/by/4.0/